Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC Zovegalisib | 2733573-94-7 | C29H14ClF5N6O2 | 1 MG
Supplier: Medchemexpress LLC HY1533061MG
Zovegalisib (RLY-2608) is an orally active, first-in-class, allosteric mutant-selective inhibitor of PI3Kα. It demonstrates anti-tumor activity by inhibiting tumor growth in PIK3CA-mutant xenograft mouse models with minimal impact on insulin levels.
- Orally active, first-in-class, allosteric mutant-selective inhibitor of PI3Kα
- Demonstrates anti-tumor activity
- Inhibits tumor growth in PIK3CA-mutant xenograft mouse models
- Minimal impact on insulin levels
- Inhibits proliferation and phosphorylated AKT (pAKT) in PIK3CA mutant cancer cell lines
- For research use only
- Storage (powder): -20°C for 3 years; 4°C for 2 years
- Storage (in solvent): -80°C for 6 months; -20°C for 1 month
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?